Publications by authors named "B Escudier"

Claim this Profile
F
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.
R J Motzer, B Escudier, M Burotto, T Powles, A B Apolo

Ann Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study.
Ronan Flippot, Yann-Alexandre Vano, Cécile Dalban, Benoit Beuselinck, Aude Fléchon, Bernard Escudier

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.
Lucía Carril-Ajuria, Ronan Flippot, Marie Naigeon, Cécile Dalban, Aude Desnoyer, Bernard Escudier

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study.
Viktor Grünwald, Axel Bex, Sylvie Rottey, Cristina Suárez, Giuseppe Procopio, Bernard Escudier

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT).
Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, Pritha Roy, Jose C Tapia, Bernard Escudier

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis